Carregant...
HER2/neu Immunostaining in Invasive Breast Cancer: Analysis of False Positive Factors
OBJECTIVES: HER2/neu gene amplification by Fluorescent in situ hybridization and protein expression by immunohistochemistry have been used for prognosis and guidance for the treatment of invasive ductal carcinoma of the breast with Trastuzumab. False positive results are a significant problem where...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
OMJ
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3191663/ https://ncbi.nlm.nih.gov/pubmed/22043354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2010.78 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|